Trial Outcomes & Findings for Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation (NCT NCT01460225)

NCT ID: NCT01460225

Last Updated: 2018-07-13

Results Overview

gastric emptying was measured before and after 7 days of treatment.at set times (2 and 4 hours post eating a radio-labeled meal)

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

19 participants

Primary outcome timeframe

Day 1 and Day 7

Results posted on

2018-07-13

Participant Flow

19 patients entered the study; no dropouts. All patients completed the study; the entire study was contacted at Dartmouth.

No patients were excluded.

Participant milestones

Participant milestones
Measure
Lubirprostone
Overall Study
STARTED
19
Overall Study
COMPLETED
19
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Lubirprostone
n=19 Participants
Age, Categorical
<=18 years
0 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
19 Participants
n=99 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
Age, Continuous
42 years
STANDARD_DEVIATION 12.5 • n=99 Participants
Sex: Female, Male
Female
16 Participants
n=99 Participants
Sex: Female, Male
Male
3 Participants
n=99 Participants
Region of Enrollment
United States
19 participants
n=99 Participants

PRIMARY outcome

Timeframe: Day 1 and Day 7

gastric emptying was measured before and after 7 days of treatment.at set times (2 and 4 hours post eating a radio-labeled meal)

Outcome measures

Outcome measures
Measure
Prior to Treatement With Lubiprostone
n=19 Participants
Post Treatment With Lubiprostone
n=19 Participants
Gastric Emptying
2 Hours after meal
0.27 percent meal retention
Standard Deviation NA
Original Data for this study have been destroyed, the study was not published and the Standard Deviation was not reported with the data in the only report available. A p= .003 was documented. This is the only measure of precision in the report.
0.384 percent meal retention
Standard Deviation NA
Original Data for this study have been destroyed, the study was not published and the Standard Deviation was not reported with the data in the only report available. A p= .003 was documented. This is the only measure of precision in the report.
Gastric Emptying
4 Hours after meal
0.04 percent meal retention
Standard Deviation NA
Original Data for this study have been destroyed, the study was not published and the Standard Deviation was not reported with the data in the only report available. A p value was documented and this is the only measure of precision in the report.
0.051 percent meal retention
Standard Deviation NA
Original Data for this study have been destroyed, the study was not published and the Standard Deviation was not reported with the data in the only report available. A p value was documented and this is the only measure of precision in the report.

Adverse Events

All- Single Arm

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
All- Single Arm
n=19 participants at risk
Gastrointestinal disorders
nausea
10.5%
2/19 • Number of events 2
General disorders
Headache
5.3%
1/19 • Number of events 1

Additional Information

Dr. Brian Lacy

Dartmouth-Hitchcock Medical Center

Phone: 603-650-5215

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place